Research News @ Vanderbiltclick here.
Schizophrenia Research Forumclick here.
The Brain & Behavior Research Foundationclick here.
VUMC Reporterclick here.
AstraZeneca IMed Biotech Unitclick here.
Determines drug metabolism, absorption and distribution, mechanisms of clearance, etc. click here.
Develops new chemical entities suitable for therapeutic use click here.
Supports assay development, high-throughput screening, and in vitro pharmacology click here.
Provides pharmacologic characterization using preclinical models of various CNS disorders click here.
Alzheimer’s disease (AD) is a progressive neurodegenerative disease click here.
Schizophrenia affects 1% of the world population click here.
Many of these disorders have associated genetic risk factors click here.
Parkinson’s impacts about a million people in the U.S. each year click here.
ACS Webinar click here.
Part of Vanderbilt Medical's Discovery Lecture Series click here.
Discoveries in Neurosciences click here.
Vanderbilt Center for Neuroscience Drug Discovery and Personalized Medicine click here.
Breakthrough Medicines for Serious Brain Disorders click here.
Conn Vanderbilt Neuroscience Drug Discovery click here.